Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.03
0.041.00%
At close: -
$3.99
-0.04-0.99%
After Hours: Jan 31, 8:25 AM EDT
Comments
Loading...
Kiora Pharmaceuticals (KPRX) Forecast
NewsEarningsKiora Pharmaceuticals (KPRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Good
Kiora Pharmaceuticals (NASDAQ:KPRX) Stock Quotes, Forecast and News Summary
Kiora Pharmaceuticals Stock (NASDAQ: KPRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kiora Pharmaceuticals (KPRX) stock?
You can purchase shares of Kiora Pharmaceuticals (NASDAQ:KPRX) through any online brokerage.
Who are Kiora Pharmaceuticals (KPRX) competitors?
There are no as such competitors for Kiora Pharmaceuticals.
What is the forecast, or price target, for Kiora Pharmaceuticals (KPRX) stock?
Kiora Pharmaceuticals has a consensus price target of $43.67.
What is the current price for Kiora Pharmaceuticals (KPRX)?
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $3.99 last updated January 31, 2025 at 8:25 AM EST.
Does Kiora Pharmaceuticals (KPRX) pay a dividend?
There are no upcoming dividends for Kiora Pharmaceuticals.
When is Kiora Pharmaceuticals (NASDAQ:KPRX) reporting earnings?
Kiora Pharmaceuticals’s Q4 earnings are confirmed for Monday, March 24, 2025.
Is Kiora Pharmaceuticals (KPRX) going to split?
There is no upcoming split for Kiora Pharmaceuticals.
What sector and industry does Kiora Pharmaceuticals (KPRX) operate in?
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.